To the Editor In an Original Investigation in a recent issue of JAMA Internal Medicine, Merkow and colleagues1 focused on the lack of clarity in cancer surveillance recommendations because of the prolongation of survival due to the innovative treatment development. They concluded that recommendations of cancer guidelines should be nonambiguous with the aim of optimizing care quality and resource use.
Schepisi G, Banna GL, De Giorgi U. Consider Quality of Life to Improve Quality of Cancer Guidelines. JAMA Intern Med. 2017;177(10):1537. doi:https://doi.org/10.1001/jamainternmed.2017.3694
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: